Millar, John S <br/><br/>
Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E.  [electronic resource] 

 -  Journal of lipid research  06 2017 
 - 1214-1220 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1539-7262 
<br/><br/><label>Standard No.: </label>10.1194/jlr.M074880  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apolipoprotein C-II--blood<br/>Apolipoprotein C-III--blood<br/>Apolipoproteins--blood<br/>Apolipoproteins E--blood<br/>Cholesterol Ester Transfer Proteins--antagonists & inhibitors<br/>Drug Interactions<br/>Female<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Lipoproteins, VLDL--metabolism<br/>Male<br/>Middle Aged<br/>Oxazolidinones--pharmacology<br/>Triglycerides--metabolism